Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat. In a new study, Scripps Research scientists have devised a way to deactivate these designer drugs after they've been administered--offering a potential path for treating addiction and overdose.
New research finds that that having hope for the future can make you happier with your lot - and protect you from risky behaviours such as drinking and gambling.
A community or sub-culture encouraging young men's exposure and obsession with guns - as well as ready access to firearms and drugs - can make gun violence 'all too easy', with Flinders University experts promoting a new direction on managing the global problem. Flinders criminologists conclude that the need to 'dematerialise' the attraction to gun has "never been greater" than "in a post-COVID-19 world in which guns have gained greater salience in many countries".
Findings released today from the most recent Monitoring the Future (MTF) survey of substance use behaviors and related attitudes among teens in the United States indicate that levels of nicotine and marijuana vaping did not increase from 2019 to early 2020, although they remain high. The annual MTF survey is conducted by the University of Michigan's Institute for Social Research, Ann Arbor, and is funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
This Viewpoint describes the planned Healthy Brain and Child Development Study, which will investigate the associations of parental substance abuse, COVID-19 and exposure to health disparities with their children's health and well-being.
Women who receive mastectomy and reconstructive surgery as part of breast cancer treatment may face the risk of developing persistent use of opioids and sedative-hypnotic drugs, according to data presented at the 2020 San Antonio Breast Cancer Symposium.
Cocaine continues to be one of the most commonly abused illicit drugs in the United States. Pre-clinical literature suggests that targeting glucagon-like peptide-1 receptors (GLP-1Rs) in the brain may represent a novel approach to treating cocaine use disorder. Specifically, GLP-1R agonists, which are FDA-approved for treating diabetes and obesity, have been shown to reduce voluntary drug taking and seeking in preclinical models of cocaine used disorder.
Emerging changes in overdose-related cardiac arrests in the U.S. during the COVID-19 pandemic are described in this observational study using a large national emergency medical services database.
New research shows from the Lambert Initiative at the University of Sydney shows that cannabidiol is safe for driving and the intoxicating effects of THC in cannabis fade in hours. The results have big implications for regulation of medical cannabis and for drug-driving laws regarding cannabis.
The use of big data to address the opioid epidemic in Massachusetts poses ethical concerns that could undermine its benefits without clear governance guidelines that protect and respect patients and society, a University of Massachusetts Amherst study concludes.